Anduril CEO Brian Schimpf said the company is not rushing to go public, warning that IPOs during hype cycles can lead to poor returns. Despite soaring demand for defense tech driven by increased military spending, Anduril and other firms face what Schimpf calls "crazy high valuations." The company recently doubled its valuation to $61 billion but prefers to stay private to scale its AI-powered defense systems. This cautious approach reflects broader skepticism about current market pricing for tech IPOs, including those in AI and space sectors.
Ross Stores is set to report Q2 earnings with analysts forecasting EPS of $1.95 and revenue of $6.16 billion, up from $1.56 EPS and $5.53 billion revenue last year. This growth is attributed to strong consumer demand for value and the addition of 47 ...
Nvidia, a leading semiconductor and AI company, is expected to report strong Q2 fiscal 2027 earnings on August 26, with analysts anticipating revenue around $91.9 billion and adjusted earnings of $2.08 per share. RBC Capital maintains an "Outperform"...
Deere & Company reported third-quarter earnings per share of $5.10, surpassing analyst expectations of $4.71, and revenue of $12.61 billion, exceeding estimates of $10.81 billion. The growth was mainly driven by strong performance in the construction...
Piper Sandler raised AbbVie's price target to $303, indicating a potential 13.92% upside from its current price of $265.97. This reflects positive expectations for the biopharmaceutical company's future performance. Institutional investors like J. M....
BTIG reaffirmed its 'Buy' rating for Glaukos and increased the price target to $202, citing strong sales growth. U.S. glaucoma sales rose 64% to $118.5 million, driven by the iDose TR product, while Corneal Health revenues grew 48% to $30.4 million, ...
